N 3 (184) 2023. P. 34–39

EFFICIENCY OF APPLICATION OPTIMIZED APROACH OF TWO-STAGE TREATMENT PERIPROSTHETIC HIP INFECTION

R. A. Kozak

State University “Institute of Traumatology and Orthopedics of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine

DOI 10.32782/2226-2008-2023-3-7

The rates of revision hip arthroplasty have doubled over the past 10 years. One of the main reasons for revisions is periprosthetic infection. Two-stage revision arthroplasty is considered the gold standard in its treatment. There is no single approach to performing a two-stage revision arthroplasty, therefore, an optimized two-stage treatment strategy for periprosthetic infection of the hip joint was proposed. The results of the treatment of 129 patients with periprosthetic infection who were receiving inpatient treatment at the “Institute of Traumatology and Orthopedics of the National Academy of Medical Sciences of Ukraine” during the period from 2013 to 2022 were analyzed. The research material was divided into two research groups. The main group included 68 (52.7%) patients with periprosthetic infection of the hip, who underwent an optimized two-stage treatment strategy. A good result of treatment was found in 92.7% of patients of the main group. An important point is the improvement in HHS hip function among patients in the follow-up array. Taking into account the good and excellent functional results in patients of the main group, which allows us to recommend the use of optimized aproach of two-stage treatment of periprosthetic hip infection in clinical practice.

Key words: periprosthetic infection, diagnosis, two-stage treatment, results.

REFERENCES

  1. Гайко ГВ, Грицай МП, Колов ГБ, Козак РА, Нізалов ТВ, Галузинський ОА. Двоетапне лікування перипротезної інфекції кульшового суглобу. Збірник наукових праць XVIII з’їзду ортопедів-травматологів. 9-11 жовтня 2019 м. Івано-Франківськ. С. 239-240
  2. Boelch SP, Rüeckl K, Streck LE, Szewczykowski V, Weißenberger M, Jakuscheit A. Diagnosis of Chronic Infection at Total Hip Arthroplasty Revision Is a Question of Definition. Biomed Res Int. 2021 Nov 19;2021:8442435. DOI: 10.1155/2021/8442435. PMID: 34840982.
  3. Chalmers BP, Mabry TM, Abdel MP, Berry DJ, Hanssen AD, Perry KI. Two-Stage Revision Total Hip Arthroplasty With a Specific Articulating Antibiotic Spacer Design: Reliable Periprosthetic Joint Infection Eradication and Functional Improvement. J Arthroplasty. 2018. Dec;33(12):3746-3753. DOI: 10.1016/j.arth.2018.08.016.
  4. Flaten D, Berrigan L, Spirkina A, Gin A. Risk of Treatment Failure for Prosthetic Joint Infections: Retrospective Chart Review in an Outpatient Parenteral Antimicrobial Therapy Program. Can J Hosp Pharm. 2023 Jan 9;76(1):14-22. doi: 10.4212/cjhp.3264. PMID: 36683659; PMCID: PMC9817224.
  5. Ford A, Holzmeister A, Rees H, Pelich B. Characterization of outcomes of 2-stage exchange arthroplasty in the treatment of prostheticjoint infections. Arthroplasty. DOI: 10.1016/j.a:th.002018.000002.000043
  6. Heckmann N, Ihn H, Stefl M, Etkin CD, Springer BD, Berry DJ, Lieberman JR. Early Results From the American Joint Replacement Registry: A Comparison With Other National Registries. J Arthroplasty. 2019 Jul;34(7S):S125-S134.e1. doi: 10.1016/j.arth.2018.12.027. PMID: 30711371.
  7. Jones CW, Selemon N, Nocon A, Bostrom M, Westrich G, Sculco PK. The Influence of Spacer Design on the Rate of Complications in Two-Stage Revision Hip Arthroplasty. J Arthroplasty. 2019 Jun;34(6):1201-1206. doi: 10.1016/j. arth.2019.02.012. Epub 2019 Feb 15. PMID: 30879874.
  8. Kildow BJ, Della-Valle CJ, Springer BD. Single vs 2-Stage Revision for the Treatment of Periprosthetic Joint Infection J Arthroplasty. 2020 Mar;35(3S):S24-S30. DOI: 10.1016/j.arth.2019.10.051.
  9. Kozaily ME, Timothy L, Tan M, Yacovelli MS. Interim spacer exchange for treatment of periprosthetic joint infection: almost half the patients fail subsequently. J Arthroplasty. 2021. https://doi.org/10.1016/j.arth.2021.08.028
  10. Kurtz SM, Lau EC, Son MS, Chang ET, Zimmerli W, Parvizi J. Are wewinning or losing the battle with periprosthetic joint infection: trends in periprosthetic joint infection and mortality risk for the Medicare population. JArthroplasty. 2018 Oct; 33(10):3238-45. Epub 2018 Jun
  11. Senard O, Houselstein T, Crémieux AC. Reasons for Litigation in Arthroplasty Infections and Lessons Learned. J Bone Joint Surg Am. 2019;101(20):1806-1811. doi: 10.2106/JBJS.19.00101.
View article PDF